tradingkey.logo
tradingkey.logo
Search

Lipocine Provides Progress Update On LPCN 1154 Phase 3 Clinical

ReutersSep 30, 2025 1:54 PM
facebooktwitterlinkedin
View all comments0

- Lipocine Inc LPCN.O:

  • LIPOCINE PROVIDES PROGRESS UPDATE ON LPCN 1154 PHASE 3 CLINICAL TRIAL IN POSTPARTUM DEPRESSION (PPD)

  • LIPOCINE INC: DSMB SAFETY REVIEW UPDATE PLANNED FOR 4Q 2025

  • LIPOCINE INC - TOPLINE RESULTS ANTICIPATED IN SECOND QUARTER OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI